Inicio > Medicina > Medicina: cuestiones generales > Tratamento da dependência de zolpidem
Tratamento da dependência de zolpidem

Tratamento da dependência de zolpidem

Jorge Fernando Rebouças Lessa / Maria Célia Brangioni / Thiago Xavier Corrêa

52,97 €
IVA incluido
Disponible
Editorial:
KS OmniScriptum Publishing
Año de edición:
2018
Materia
Medicina: cuestiones generales
ISBN:
9786139660506
52,97 €
IVA incluido
Disponible

Selecciona una librería:

  • Librería Samer Atenea
  • Librería Aciertas (Toledo)
  • Kálamo Books
  • Librería Perelló (Valencia)
  • Librería Elías (Asturias)
  • Donde los libros
  • Librería Kolima (Madrid)
  • Librería Proteo (Málaga)
Sobre IBD

Introdução: O zolpidem é um hipnótico não-benzodiazepínico, utilizado para tratamento de insônia, que se liga seletivamente na unidade alfa1 dos receptores GABA. As doses terapêuticas variam de 5mg a 10mg ao dia. O uso contínuo, bem como doses acima do relatado estão associadas a perda de memória, tolerância, dependência, síndrome de abstinência. Esta, com sintomas ansiosos, alterações do sono, disfunção autonômica e crises convulsivas. Objetivos: Analisar 40 casos clínicos descritos na literatura como série de casos de dependência de Zolpidem e seu tratamento, bem como a presença de patologias psiquiátricas associados.

Artículos relacionados

  • 48 Recettes de Repas pour l'élimination de l'acné
    Joe Correa
    48 Recettes de Repas pour ’élimination de l’acné : La voie rapide et naturelle de correction des problèmes d'acné en 10 jours ou moins! Par Joe Correa CSN   Ces recettes vous aideront à avoir un système immunitaire plus fort grâce à une variété de vitamines et de nutriments. Environ 20 pour cent de toutes les personnes souffrent d'acné pendant 20 et 30 ans, et la cau...
    Disponible

    20,65 €

  • 54 Ricette per diabetici per controllare la tua condizione, naturalmente
    Joe Correa
    54 Ricette Per Diabetici Per Controllare La Tua Condizione, Naturalmente: Scelte Alimentari Sane Per Tutti I DiabeticiDi Joe Correa CSN Il diabete si verifica a causa della incapacità del pancreas di produrre insulina. Il diabete di tipo 1 è classificato come una malattia autoimmune. È una condizione in cui il sistema immunitario dell'organismo 'attacca' i propri tessuti e ...
    Disponible

    22,29 €

  • Ubiquitous Cardiology
    Piotr Augustyniak / Ryszard Tadeusiewicz
    The Internet and other technological developments are now playing increasing roles in consumer health and the delivery of health services. Ubiquitous Cardiology: Emerging Wireless Telemedical Applications provides developmental solutions and explanations for cardiovascular diagnostics. Useful to field researchers, academicians, and healthcare practitioners, this Premier Referen...
  • Quality Assurance in Healthcare Service Delivery, Nursing and Personalized Medicine
    Quality of life is difficult to define and even more difficult to measure; as such, outcomes from nursing in continuing care are not easily articulated. Quality Assurance in Healthcare Service Delivery, Nursing and Personalized Medicine: Technologies and Processes offers a framework for measuring quality of service in the healthcare industry as it pertains to nursing, with insi...
  • Exploring the Pressures of Medical Education From a Mental Health and Wellness Perspective
    Christina Ramirez Smith
    Discussions surrounding mental health are becoming more prominent and these conditions are becoming less stigmatized. Studying the effects that mental wellness has on students within the medical field can provide an insider perspective on this critical topic. Exploring the Pressures of Medical Education From a Mental Health and Wellness Perspective is a critical reference sourc...
  • Electrocardiogram Signal Classification and Machine Learning
    Sara Moein
    Technological tools and computational techniques have enhanced the healthcare industry. These advancements have led to significant progress in the diagnosis of heart disorders. Electrocardiogram Signal Classification and Machine Learning: Emerging Research and Opportunities is a critical scholarly resource that examines the importance of automatic normalization and classificati...

Otros libros del autor

  • Behandlung der Zolpidem-Abhängigkeit
    Jorge Fernando Rebouças Lessa / Maria Célia Brangioni / Thiago Xavier Corrêa
    Einleitung: Zolpidem ist ein Nicht-Benzodiazepin-Hypnotikum zur Behandlung von Schlaflosigkeit, das selektiv an die Alpha1-Einheit der GABA-Rezeptoren bindet. Die therapeutischen Dosen reichen von 5 mg bis 10 mg pro Tag. Die kontinuierliche Einnahme sowie höhere Dosen werden mit Gedächtnisverlust, Toleranz, Abhängigkeit und Entzugssyndrom in Verbindung gebracht. Letzteres ist m...
    Disponible

    49,51 €

  • Treatment of zolpidem dependence
    Jorge Fernando Rebouças Lessa / Maria Célia Brangioni / Thiago Xavier Corrêa
    Introduction: Zolpidem is a non-benzodiazepine hypnotic used to treat insomnia, which selectively binds to the alpha1 unit of GABA receptors. Therapeutic doses range from 5mg to 10mg a day. Continuous use, as well as doses above those reported, are associated with memory loss, tolerance, dependence and withdrawal syndrome. The latter is associated with anxiety symptoms, sleep d...
    Disponible

    49,45 €

  • Trattamento della dipendenza da zolpidem
    Jorge Fernando Rebouças Lessa / Maria Célia Brangioni / Thiago Xavier Corrêa
    Introduzione: lo zolpidem è un ipnotico non benzodiazepinico utilizzato per il trattamento dell’insonnia, che si lega selettivamente all’unità alfa1 dei recettori GABA. Le dosi terapeutiche variano da 5 a 10 mg al giorno. L’uso continuo, così come dosi superiori a quelle riportate, sono associati a perdita di memoria, tolleranza, dipendenza e sindrome da astinenza. Quest’ultima...
    Disponible

    49,45 €

  • Traitement de la dépendance au zolpidem
    Jorge Fernando Rebouças Lessa / Maria Célia Brangioni / Thiago Xavier Corrêa
    Introduction : Le zolpidem est un hypnotique non-benzodiazépine utilisé pour traiter l’insomnie, qui se lie sélectivement à l’unité alpha1 des récepteurs GABA. Les doses thérapeutiques varient de 5 à 10 mg par jour. L’utilisation continue, ainsi que les doses supérieures à celles rapportées, sont associées à des pertes de mémoire, une tolérance, une dépendance et un syndrome de...
    Disponible

    49,51 €